What Transformation Has the Cardiac Arrhythmia Monitoring Devices Market Undergone?
The cardiac arrhythmia monitoring devices market has seen considerable growth due to a variety of factors.
• The market for cardiac arrhythmia monitoring devices has seen significant growth in recent years. It is expected to rise from a value of $7.83 billion in 2024 to reach $8.43 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%. This growth during the historical period is a consequence of factors such as increased risks associated with lifestyle choices, worldwide advancements in healthcare services, patient inclination towards home-based monitoring, awareness and screening initiatives, along with a growing incidence of cardiovascular conditions.
What Are The Predictions for The Cardiac Arrhythmia Monitoring Devices Market Size In The Coming Years?
The Cardiac Arrhythmia Monitoring Devices market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipations are high for a significant expansion in the cardiac arrhythmia monitoring devices market in the upcoming years. The market is predicted to escalate to $12.09 billion in 2029, with a compound annual growth rate (CAGR) of 9.4%.
This projected growth within the forecast period can be credited to the broadening of telehealth services, an emphasis on uninterrupted monitoring, the emergence of smart apparel for monitoring, early intervention strategies, the creation of user-congenial device design, and enhancing patient empowerment and involvement. Key trends to look out for during the forecast period encompass the surge in wearable technology, the incorporation of artificial intelligence (AI), ongoing ECG monitoring devices, miniaturisation and portability, the connectivity with smartphones and corresponding apps, long-term monitoring resolutions, and novel developments in implantable apparatus.
Which Drivers Are Accelerating Growth In The Cardiac Arrhythmia Monitoring Devices Market?
The escalating occurrence of cardiovascular disorders is anticipated to spur the expansion of the cardiac arrhythmia monitoring devices market in the future. Cardiovascular diseases encompass a range of ailments related to heart and blood vessel conditions such as atherosclerosis, angina, heart attacks, aortic disease, among others. Cardiac arrhythmia monitoring devices play a crucial role in these diseases by providing event monitoring, recording the patient's heart rhythm and beat (ECG), and identifying the potential of irregular heartbeats (arrhythmias). For example, HMP Global, a patient-focused educational firm based in the US, projected in April 2023 that the occurrence of peripheral arterial disease in the US is expected to increase to 23.8 million by 2030, up from 21.0 million in 2020. Thus, the escalating occurrence of cardiovascular disorders serves as a catalyst for the expansion of the cardiac arrhythmia monitoring devices market.
What Are The Core Segments Of The Global Cardiac Arrhythmia Monitoring Devices Market?
The cardiac arrhythmia monitoring devices market covered in this report is segmented –
1) By Type: Standards in Ambulatory Cardiac Monitoring, Patient- and Event-activated Intermittent Recorders, External Loop Recorder Pre-symptom Memory Loop Cardiac Event Recorder, Post-symptom Event Recorder, Continuous Real-time Attended Remote Cardiac Monitors, Mobile Cardiac Outpatient Telemetry System, Vital Signs Transmitter (Bio Watch Medical)
2) By Device: Holter Monitor, Event Recorder, Mobile Cardiac Telemetry, Implantable Cardiac Monitor, Electrocardiogram (ECG) Monitor, Other Devices
3) By Application: Tachycardia, Bradycardia, Premature Contraction, Other Applications
4) By End-use: Hospitals and Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, Other End-uses
Subsegments:
1) By Standards In Ambulatory Cardiac Monitoring: Holter Monitors, Mobile Cardiac Telemetry (MCT), Event Monitors
2) By Patient- And Event-Activated Intermittent Recorders: Handheld Recorders, Wearable Event Monitors
3) By External Loop Recorder: Pre-Symptom Memory Loop Cardiac Event Recorder, Post-Symptom Event Recorder
4) By Continuous Real-Time Attended Remote Cardiac Monitors: Hospital-Based Monitors, Home-Based Monitors
5) By Mobile Cardiac Outpatient Telemetry System: Wireless Telemetry Systems, Real-Time Data Transmission Devices
6) By Vital Signs Transmitter (Bio Watch Medical): Remote Monitoring Systems, Integration With Mobile Health Applications
Pre-Book The Cardiac Arrhythmia Monitoring Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Cardiac Arrhythmia Monitoring Devices Market Size?
Key businesses in the cardiac arrhythmia monitoring devices market are concentrating their efforts on inventing cutting-edge solutions such as cardiac monitoring products. These products aim to increase the precision of arrhythmia detection by boosting patient diagnostic capabilities. Cardiac monitoring products are essentially medical apparatus or systems engineered to monitor either continuously or sporadically the overall functionality and electric activity of the heart. For example, in January 2023, UltraLinQ, an American medical technology manufacturing company, presented its latest cardiac monitoring product at the Arab Health exhibition. Their system provides one-week continuous heart rhythm monitoring, thereby significantly escalating arrhythmia detection rates from 45% to almost 97%, as compared to the usual Holter monitors that record data only for a day. The system incorporates disposable, single-use wearable biosensors which let patients go about their daily chores such as exercising, sleeping, and showering without any wiring. Holter reports can be prepared within 36 hours by accredited cardiac technicians, providing prompt insights into cardiac health. UltraLinQ’s cloud platform further adds to its appeal by granting healthcare providers the ability to access medical images and data from any place, thus increasing its adaptability.
Who Are the Key Players In The Cardiac Arrhythmia Monitoring Devices Market?
Major companies operating in the cardiac arrhythmia monitoring devices market include:
• AliveCor Inc.
• Biotronik SE & Co. KG
• General Electric Company
• iRhythm Technologies Inc.
• Koninklijke Philips N.V.
• Medtronic PLC
• Nihon Kohden Corporation
• Smart Solutions Technologies S.L.
• Abbott Laboratories
• OSI Systems Inc.
• Hill-Rom Holdings Inc.
• Applied Cardiac System Diagnostics Inc.
• Biotricity Inc.
• Boston Scientific Corporation
• Medicalgorithmics S.A.
• Siemens AG
• Edwards Lifescience Corporation
• LivaNova PLC
• Phoenix Heart Center
• Fukuda Denshi Co. Ltd.
• Royal Philips
• NUUBO SMART SOLUTIONS S.L
• Cardiac Insight Inc.
• CardioComm Solutions Inc.
• Vascular Solutions Inc.
• Johnson & Johnson Services Inc.
• MicroPort Scientific Corporation
• Osypka AG
• AtaCor Medical
• Spacelabs Healthcare
What Are The Regional Insights Into The Cardiac Arrhythmia Monitoring Devices Market?
North America was the largest region in the cardiac arrhythmia monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cardiac arrhythmia monitoring devices market report during the forecast period. The regions covered in the cardiac arrhythmia monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
